n.a. (ASTX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Astex Pharmaceuticals To Present At World Epigenetics Summit On December 8th

Astex Pharmaceuticals To Present At World Epigenetics Summit On December 8th

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, today announced that Tom Heightman, Ph.

Astex Pharmaceuticals To Present At Piper Jaffray Health Care Conference On November 29th

Astex Pharmaceuticals To Present At Piper Jaffray Health Care Conference On November 29th

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, today announced that James S.

Astex Pharmaceuticals To Present At Lazard Healthcare Conference On November 16th

Astex Pharmaceuticals To Present At Lazard Healthcare Conference On November 16th

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, today announced that James S.

Astex Pharmaceuticals To Present At AACR-NCI-EORTC

Astex Pharmaceuticals To Present At AACR-NCI-EORTC

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, announced the acceptance of four abstracts detailing recent work with Astex...

Astex Pharmaceuticals Reports 2011 Third Quarter Financial Results

Astex Pharmaceuticals Reports 2011 Third Quarter Financial Results

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), formerly SuperGen, Inc.

Astex Pharmaceuticals To Present A Novel Targeted Approach To The Treatment Of HCV At The AASLD Meeting

Astex Pharmaceuticals To Present A Novel Targeted Approach To The Treatment Of HCV At The AASLD Meeting

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics, announced that it will present data on its novel, first-in-class...

Astex Pharmaceuticals To Announce 2011 Third Quarter Financial Results On October 31, 2011

Astex Pharmaceuticals To Announce 2011 Third Quarter Financial Results On October 31, 2011

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery, development and commercialization of novel cancer therapies, announced that it will release its 2011 third quarter ...

Astex Pharmaceuticals To Present At BIO Investor Forum On October 26th

Astex Pharmaceuticals To Present At BIO Investor Forum On October 26th

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery, development and commercialization of novel cancer therapies, today announced that James S.

Astex Pharmaceuticals To Present At NewsMakers In The Biotech Industry On October 21st

Astex Pharmaceuticals To Present At NewsMakers In The Biotech Industry On October 21st

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery, development and commercialization of novel cancer therapies, today announced that James S.

Evidence Of AT13387 Activity In Gastrointestinal Stromal Tumor Models Presented At ECCO

Evidence Of AT13387 Activity In Gastrointestinal Stromal Tumor Models Presented At ECCO

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that preclinical data demonstrating that AT13387, a novel ...

Astex Pharmaceuticals To Present At Jefferies Global Healthcare Conference On September 27th

Astex Pharmaceuticals To Present At Jefferies Global Healthcare Conference On September 27th

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that Harren Jhoti, Ph.

Astex Pharmaceuticals To Present At UBS Global Life Sciences Conference On September 21st

Astex Pharmaceuticals To Present At UBS Global Life Sciences Conference On September 21st

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.